Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

NCT00389870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1198

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: cyclosporine
DRUG: irinotecan hydrochloride

Sponsor

University of Leeds